Skip to main content
. 2019 Jan 2;177(3):490–502. doi: 10.1111/bph.14550

Figure 2.

Figure 2

The role of histamine H4 receptors on human cells relevant to psoriasis. H4 receptors (H4R) are expressed on keratinocytes and different immune cells, which play a role in psoriasis. Triggering the complement component 5a receptor (C5aR) on mast cells leads to release of histamine. Histamine acts via H4 receptors on Th17 cells to release IL‐17 and promotes NK cells to produce CCL3 and CCL4. Stressed keratinocytes release self‐DNA, which in turn activates pDCs to produce IFN‐α. The stimulation of H4 receptors on pDCs suppresses the secretion of the TNF‐α, IFN‐α and CXCL8. Histamine reduces, via H4 receptors, the release of the chemokines CXCL10 or CXCL10 and CCL4 in APCs and macrophages respectively. Histamine itself induces chemotaxis via H4 receptors of γδ T‐cells, NK cells and of pDCs. The anti‐inflammatory effects of the H4 receptors seem to be more pronounced when compared with the inflammatory effects of the receptor in the pathophysiology of psoriasis. Thus, H4 receptor agonists, rather than H4 receptor antagonists, may prevent amplification of the symptoms. The effects mediated by H4 receptors are highlighted in red.